Gladius Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,500
| Closed | -$878K | – | 77 |
|
|
2026
Q1 | $902K | Buy |
+7,500
| New | +$866K | 0.04% | 93 |
|
|
2025
Q2 | – | Sell |
-11,848
| Closed | -$1.06M | – | 73 |
|
|
2025
Q1 | $1.06M | Sell |
11,848
-291
| -2% | -$27.2K | 0.28% | 57 |
|
|
2024
Q4 | $1.21M | Sell |
12,139
-2,724
| -18% | -$281K | 0.13% | 70 |
|
|
2024
Q3 | $1.69M | Buy |
14,863
+9,246
| +165% | +$1.1M | 0.2% | 55 |
|
|
2024
Q2 | $695K | Buy |
5,617
+4,292
| +324% | +$553K | 0.09% | 95 |
|
|
2024
Q1 | $175K | Buy |
+1,325
| New | +$163K | 0.06% | 130 |
|
|
2023
Q4 | – | Sell |
-35,938
| Closed | -$3.73M | – | 379 |
|
|
2023
Q3 | $3.7M | Buy |
+35,938
| New | +$3.87M | 0.15% | 96 |
|
|
2023
Q2 | – | Sell |
-20,638
| Closed | -$2.34M | – | 430 |
|
|
2023
Q1 | $2.2M | Buy |
20,638
+17,955
| +669% | +$1.94M | 0.13% | 81 |
|
|
2022
Q4 | $298K | Sell |
2,683
-8,223
| -75% | -$841K | 0.02% | 121 |
|
|
2022
Q3 | $940K | Buy |
10,906
+9,343
| +598% | +$834K | 0.04% | 111 |
|
|
2022
Q2 | $143K | Buy |
1,563
+896
| +134% | +$79.4K | 0.01% | 172 |
|
|
2022
Q1 | $55K | Sell |
667
-1,798
| -73% | -$142K | ﹤0.01% | 262 |
|
|
2021
Q4 | $189K | Buy |
+2,465
| New | +$196K | 0.02% | 187 |
|
|
2021
Q2 | – | Sell |
-25,472
| Closed | -$1.89M | – | 158 |
|
|
2021
Q1 | $1.87M | Buy |
25,472
+15,586
| +158% | +$1.15M | 0.07% | 123 |
|
|
2020
Q4 | $772K | Buy |
9,886
+6,350
| +180% | +$486K | 0.04% | 148 |
|
|
2020
Q3 | $280K | Buy |
+3,536
| New | +$277K | 0.03% | 155 |
|
|
2020
Q2 | – | Sell |
-12,022
| Closed | -$883K | – | 89 |
|
|
2020
Q1 | $883K | Buy |
+12,022
| New | +$945K | 0.09% | 98 |
|
|
2019
Q4 | – | Sell |
-64,221
| Closed | -$5.27M | – | 194 |
|
|
2019
Q3 | $5.16M | Buy |
64,221
+14,207
| +28% | +$1.14M | 0.24% | 81 |
|
|
2019
Q2 | $4.04M | Buy |
50,014
+25,263
| +102% | +$1.93M | 0.24% | 43 |
|
|
2019
Q1 | $1.96M | Sell |
24,751
-39,036
| -61% | -$2.92M | 0.11% | 89 |
|
|
2018
Q4 | $4.65M | Buy |
63,787
+60,934
| +2,136% | +$4.3M | 0.23% | 73 |
|
|
2018
Q3 | $193K | Sell |
2,853
-8,464
| -75% | -$539K | 0.02% | 73 |
|
|
2018
Q2 | $655K | Buy |
+11,317
| New | +$638K | 0.07% | 61 |
|
Other funds holding MRK
Gladius Capital Management's MRK Position: Q2 2026 in Review
Gladius Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 7,500 shares — an estimated $878K sold.
Gladius Capital Management first reported a position in MRK in Q2 2018 and held it in 23 quarters. The position peaked at $5.16M in Q3 2019. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gladius Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Gladius Capital Management sold 7,500 Merck shares in Q2 2026, an estimated $878K.
- Gladius Capital Management first reported a position in Merck in Q2 2018 and held it in 23 quarters.
- Gladius Capital Management's Merck position peaked at $5.16M in Q3 2019.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gladius Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.